Annual Interest Expense
$2.83 M
-$198.00 K-6.53%
31 December 2023
Summary:
Cartesian Therapeutics annual interest expense is currently $2.83 million, with the most recent change of -$198.00 thousand (-6.53%) on 31 December 2023. During the last 3 years, it has risen by +$1.28 million (+82.07%). RNAC annual interest expense is now -6.53% below its all-time high of $3.03 million, reached on 31 December 2022.RNAC Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
$0.000.00%
01 September 2024
Summary:
Cartesian Therapeutics quarterly interest expense is currently $0.00, unchanged on 01 September 2024. Over the past year, it has dropped by -$1.27 million (-100.00%). RNAC quarterly interest expense is now -100.00% below its all-time high of $1.27 million, reached on 30 September 2023.RNAC Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$0.00
-$1.27 M-100.00%
01 September 2024
Summary:
Cartesian Therapeutics TTM interest expense is currently $0.00, with the most recent change of -$1.27 million (-100.00%) on 01 September 2024. Over the past year, it has dropped by -$3.64 million (-100.00%). RNAC TTM interest expense is now -100.00% below its all-time high of $3.64 million, reached on 30 September 2023.RNAC TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -100.0% | -100.0% |
| 3 y3 years | +82.1% | -100.0% | -100.0% |
| 5 y5 years | +89.6% | -100.0% | -100.0% |
RNAC Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.5% | +82.1% | -100.0% | -100.0% | ||
| 5 y | 5 years | -6.5% | +89.6% | -100.0% | -100.0% | ||
| alltime | all time | -6.5% | +413.2% | -100.0% | -100.0% |
Cartesian Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2024 | - | $0.00(0.0%) | $1.27 M(-37.1%) |
| Mar 2024 | - | $0.00(0.0%) | $2.02 M(-28.5%) |
| Dec 2023 | $2.83 M(-6.5%) | $0.00(-100.0%) | $2.83 M(-22.2%) |
| Sept 2023 | - | $1.27 M(+69.3%) | $3.64 M(+14.9%) |
| June 2023 | - | $752.00 K(-6.9%) | $3.17 M(+1.2%) |
| Mar 2023 | - | $808.00 K(+0.1%) | $3.13 M(+3.3%) |
| Dec 2022 | $3.03 M(+6.6%) | - | - |
| Dec 2022 | - | $807.00 K(+0.6%) | $3.03 M(+3.3%) |
| Sept 2022 | - | $802.00 K(+12.2%) | $2.94 M(+3.2%) |
| June 2022 | - | $715.00 K(+1.1%) | $2.84 M(+0.1%) |
| Mar 2022 | - | $707.00 K(-0.6%) | $2.84 M(-0.1%) |
| Dec 2021 | $2.84 M(+82.8%) | $711.00 K(0.0%) | $2.84 M(-0.1%) |
| Sept 2021 | - | $711.00 K(0.0%) | $2.85 M(+13.8%) |
| June 2021 | - | $711.00 K(0.0%) | $2.50 M(+25.4%) |
| Mar 2021 | - | $711.00 K(-0.3%) | $1.99 M(+28.1%) |
| Dec 2020 | $1.56 M(+2.4%) | $713.00 K(+95.3%) | $1.56 M(+32.1%) |
| Sept 2020 | - | $365.00 K(+78.0%) | $1.18 M(-1.9%) |
| June 2020 | - | $205.00 K(-24.9%) | $1.20 M(-14.0%) |
| Mar 2020 | - | $273.00 K(-18.5%) | $1.40 M(-8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $1.52 M(+1.7%) | $335.00 K(-13.7%) | $1.52 M(-3.8%) |
| Sept 2019 | - | $388.00 K(-3.0%) | $1.58 M(+0.3%) |
| June 2019 | - | $400.00 K(+1.0%) | $1.57 M(+2.3%) |
| Mar 2019 | - | $396.00 K(+0.3%) | $1.54 M(+3.1%) |
| Dec 2018 | $1.49 M(+23.9%) | $395.00 K(+2.9%) | $1.49 M(+2.5%) |
| Sept 2018 | - | $384.00 K(+5.2%) | $1.46 M(+8.6%) |
| June 2018 | - | $365.00 K(+4.3%) | $1.34 M(+6.8%) |
| Mar 2018 | - | $350.00 K(-2.5%) | $1.26 M(+4.1%) |
| Dec 2017 | $1.21 M(-3.8%) | $359.00 K(+34.0%) | $1.21 M(+3.2%) |
| Sept 2017 | - | $268.00 K(-3.9%) | $1.17 M(-3.5%) |
| June 2017 | - | $279.00 K(-7.0%) | $1.21 M(-2.5%) |
| Mar 2017 | - | $300.00 K(-6.8%) | $1.24 M(-0.8%) |
| Dec 2016 | $1.25 M(+32.2%) | $322.00 K(+3.5%) | $1.25 M(+20.9%) |
| Sept 2016 | - | $311.00 K(+0.3%) | $1.04 M(-2.2%) |
| June 2016 | - | $310.00 K(0.0%) | $1.06 M(-1.9%) |
| Mar 2016 | - | $310.00 K(+195.2%) | $1.08 M(+13.8%) |
| Dec 2015 | $948.00 K(+71.7%) | $105.00 K(-68.6%) | $948.00 K(+12.5%) |
| Sept 2015 | - | $334.00 K(+1.2%) | $843.00 K(+65.6%) |
| June 2015 | - | $330.00 K(+84.4%) | $509.00 K(+184.4%) |
| Mar 2015 | - | $179.00 K | $179.00 K |
| Dec 2014 | $552.00 K | - | - |
FAQ
- What is Cartesian Therapeutics annual interest expense?
- What is the all time high annual interest expense for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual interest expense year-on-year change?
- What is Cartesian Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly interest expense year-on-year change?
- What is Cartesian Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM interest expense year-on-year change?
What is Cartesian Therapeutics annual interest expense?
The current annual interest expense of RNAC is $2.83 M
What is the all time high annual interest expense for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual interest expense is $3.03 M
What is Cartesian Therapeutics annual interest expense year-on-year change?
Over the past year, RNAC annual interest expense has changed by -$198.00 K (-6.53%)
What is Cartesian Therapeutics quarterly interest expense?
The current quarterly interest expense of RNAC is $0.00
What is the all time high quarterly interest expense for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly interest expense is $1.27 M
What is Cartesian Therapeutics quarterly interest expense year-on-year change?
Over the past year, RNAC quarterly interest expense has changed by -$1.27 M (-100.00%)
What is Cartesian Therapeutics TTM interest expense?
The current TTM interest expense of RNAC is $0.00
What is the all time high TTM interest expense for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM interest expense is $3.64 M
What is Cartesian Therapeutics TTM interest expense year-on-year change?
Over the past year, RNAC TTM interest expense has changed by -$3.64 M (-100.00%)